Mary Haak-Frendscho, PhD, will present the opening plenary on Tuesday, May 22, at the CSPS Conference, speaking on The View from Here: Innovation Canadian Style. Her presentation will provide an investor perspective on the Canadian innovation ecosystem, as seen through a US biotech lens. What we see, filling the gaps and leveraging our unique strengths. The talk will wrap up with a Q&A session.
Mary is CEO of Blueline Bioscience in Toronto and a Venture Partner with Versant Ventures. Previously, she established and served as Chairman of Compugen, Inc., was CEO and member of the Board at Igenica Biotherapeutics, Inc., and established and was President, Chief Scientific Officer and Board member of Takeda San Francisco. Mary began her industry career at Genentech, where she played a key role in the development of omalizumab (Xolair®) for the treatment of severe asthma and CIU.
Following that is Industry Day: Innovation and Management of Modern Pharmaceuticals, which will showcase speakers from MaRS Innovation, JLABs, and innovative biotech companies within the Toronto area and beyond.
The Canadian Society for Pharmaceutical Sciences (CSPS) 2018 Conference, being held May 22-25, 2018, is a joint conference with Canadian Society of Pharmacology and Therapeutics (CSPT) and Canadian Chapter of Controlled Release Society (CC-CRS). The conference will also cover topics such as Immuno-Oncology, Regulatory Reform, Translational Medicine, and more. See Conference Program.
Reserve your seat by April 10th to save $200 on your Symposium registration.